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Abstract 
Background: Before 1970, only 9 countries had dengue. Until 1998, there were 1.2 billion 
dengue infected cases in 56 different countries around the globe. To date it is prevalent in all 
of 6 WHO regions. Mortality rate is thought to be 2.5% as it varies from country to country. 
These figures are not surely depicting exact situation as many cases from most parts of the 
underdeveloped and developing countries go unreported due to number of reasons but one 
thing is sure that it is on accelerating note. 
Methodology: It is estimated total number of dengue victims around the globe from year 
2000-2009. Data were collected from World Health Organization (WHO), different health 
and country specific emergency dealing agencies and hospitals. We have shown dengue 
statistics in annotated maps of international regions where dengue has affected in certain.  In 
a country specific (Pakistan) study we have determined most vulnerable population group 
among society, their age, gender and immunological profile against dengue virus. Moreover, 
most prevalent serotype of dengue virus is determined by surveying the current data.  
Results: It is estimated that there were 24,956 lives lost world wide during 2000-2009 as a 
consequence of dengue infection (DF/DHF/DSS) with an average CFR of 0.24%. These 
figures are approximate as we have not included the unauthentic source figures from non-
reporting (to WHO) countries or not having an official database. A total of 10,178,624 
clinical cases had been reported during that period with highest share of Americas of 
6,586,785 cases. 
Conclusion: Our estimate suggests that number of dengue cases got elevated in first decade 
of 21st century but death rate is not that higher as 2-2.5% which is estimated. Dengue is 
spreading and finding novel places as temperature and travelling is getting increased.  
Open Access  
§Corresponding Author: Shafique Ahmed (Email: shafiq.cemb@gmail.com) 
1National Centre of Excellence in Molecular Biology (CEMB), University of the Punjab, Lahore - Pakistan 
2Mayo Hospital, King Edward Medical University, Lahore- Pakistan 
3Department of Pathology, University of Veterinary and Animal Sciences, Lahore - Pakistan  
4Chairman, Mayo Hospital Research Cell, Lahore- Pakistan 
5Director, Institute of Biochemistry and Biotechnology, University of Veterinary and Animal Sciences, Lahore - 
Pakistan 
INTERNATIONAL JOURNAL “Advancements in Life Sciences” ARTICLE 
 
Date Received: 09/01/2013; Date Revised: 09/28/2013; Date Published Online: 10/25/2013 
   
4 | A d v a n c e m e n t s  i n  L i f e  S c i e n c e s  V o l .  1 ,  I s s u e  1  
 
Introduction 
First decade has witnessed a lot of 
deadly disasters from 9/11 to tsunami and 
earth quakes. It also brought magnified 
dengue. Dengue fever is not new to this 
world. AB Rush, for the first time in 1779, 
noticed it as of a different kind of fever in 
Philadelphia and called it “bilious remitting 
fever” [1] but theory exists that this is even 
older than 1780s. Dengue does not have 
contagious history. It erupts as an endemic 
after every 4-5 years to be approximate. 
1907 has proved the landmark year when 
dengue was declared as the second most 
prevalent viral disease [2] and 1998 was the 
D-year (dengue year) for Philippines when it 
witnessed dengue as epidemic claiming over 
500 deaths first time in history [3]. Globally, 
1998 was the most effective year of  20th 
century with 1,300,000 cases recorded in 
just three WHO health regions South East 
Asia, Western Pacific and Americas 
followed by 1997 with 850,000 cases [1]. It 
was declared endemic in 112 countries by 
the end of 2004 [4]. Death and disease 
counts associated with first decade of 21st 
century vary greatly from country to 
country. Mortality rate ranges from 0.5-
3.5% for effected Asian countries [5]. 
Disease prevalence depends upon the 
climate, expansion of both vector and 
victim, travelling and migration [6], 
sanitation facilities of the areas, public 
awareness, medical facilities and the 
precautionary measure taken against dengue 
vector by people or governments on 
domestic and regional  level [7].  These all 
factors control the amplification of dengue. 
Aedesaegypti and Aedes albopictus are the 
primary and secondary vectors for dengue 
respectively. A. aegypti is highly 
domesticated and adaptive insect [8]. Hot 
and humid weather conditions favor the 
survival and reproduction of A. aegypti, that 
is why affected regions includes tropics, 
sub-tropics, Americas, Southeast Asia, 
South Asia, Eastern Mediterranean, Pacific 
and Africa [9]. Among half world of the 
susceptible  population [10],  975 million of 
vulnerable people live in urban areas of 
tropics and subtropics [8]. Amazingly, A. 
albopictus is ranked 4th in top 100 invasive 
species [11]  
[http://www.issg.org/database/species/search
.asp?st=100ss&fr=1&str=&lang=EN]. This 
makes dengue even more prevalent.   A 
glimpse of dengue situation and increasing 
trend from 1960 to 1998 is given in figure 1 
(World Health Organization. Prevention and 
control of dengue and dengue hemorrhagic 
fever: comprehensive guidelines: WHO 
Regional publication, SEARO, No 29 1999. 
As our globe is warming up so  A. 
albopictus is extending its sting to newer 
places. France is an effective example in 
Europe [11][12]. Cases has started showing 
up in Germany, Belgium, Sweden and 
United Kingdom [13]. Some developing 
countries, like Pakistan and Senegal has 
faced severe epidemic during the 2006-2010 
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Graph 1: Average number of cases reported worldwide annually 
in a given decade 
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but no data have been submitted to WHO or 
any other international surveillance group 
[14]. This makes it a challenging task to 
estimate the total suffered humanity and 
lives lost in fighting against dengue. 
Underreporting is also a serious issue. 
According to one estimate under-reporting 
in Cambodia and Thailand is 1.4-9.6 times 
than the original cases. Besides this, 
severity, timing and level of dengue varies 
with countries and regions. Dengue cases 
showed region-specific peaks for South 
America (March), Southeast Asia (June, 
September), South Central Asia (October) 
and the Caribbean (August, October) [15]. 
For this, to calculate the exact morbidity and 
mortality rate we collected data from 
different global hot spots of the dengue. 
Designing future frame work, health budget 
allocation and prevention strategies 
including development of direct therapies 
are majorly depending on determination of 
exact effected world’s population. 
Methods 
To calculate the total infected population for 
last decade 2000-2009, we took data from 
different sources. DengueNet, a service 
provided by WHO for international dengue 
surveillance, is used to get empirical data of 
82 WHO member countries [16]. Seventy-
three (of 82) countries have not submitted 
their regional data for the period of 2006-
2009 to central DengueNet of WHO. For the 
non-reporting period, we collected data from 
Centre for Arbovirus Reference & Research 
(Dengue/Dengue Haemorrhagic Fever) 
Malaysia, Centre for Ecology, Taxonomy 
and Control of Vectors of Malaria, Filariasis 
and Dengue Malaysia, Centre for Dengue 
and Dengue Hemorrhagic Fever Reference 
and Research, Puerto Rico, Centre for Case 
Management of Dengue Fever (DF), 
Thailand, Centre for Insecticide Resistance 
and Insecticide Research on Chagas and 
Dengue Vectors, Argentina, Centre for the 
Study and Control of Dengue, Cuba, Pan 
American Health Organization (PAHO), 
United States of America and European 
Network for Imported Viral Disease 
(ENVID-CLRN). For 2010-2012 Google 
Dengue Trends is used as reference for these 
countries: Brazil, Argentina and India. To 
present the exact epidemiological picture of 
other potential hot-spot countries for the 
given decade we collected data through 
different resources like health departments, 
emergency dealing agencies and news 
reports. These countries include Pakistan, 
Senegal and Saudi Arabia. News reports 
may not be completely reliable but do 
provide the sense of situation. Pakistan has 
faced strong endemic in 2006, 2010 and 
2011 but not even the name of this country, 
among other endemic struck countries in 
WHO list, is mentioned. This could be 
because of unavailability of data, 
international loneliness or country’s other 
hyper issues. To judge situation for Pakistan, 
we have done a model serological survey in 
2011 at the time of high epidemic from Oct 
to Dec 2011 on central public hospital. 
Results 
Estimation of Effected Human Population 
Worldwide: 
According to our estimate, during 2000-
2009, a total of approximately 10,178,624 
people in 79 countries had dengue infection 
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in any of its three forms. This data could 
have small variation because there are 
difference between data of the regional 
offices and central offices of WHO. Where 
there is difference, we relied on central 
office/DengueNet data. Countries are 
divided into 7 groups according to number 
of effected people. First group includes 
nations with above 500,000 dengue patient 
per-decade (2000-2009). Brazil stood first, 
as often [17], among 4 countries of the first 
group with 2,047,270 dengue victim . 3 out 
of 4 countries (Indonesia, Thailand and Viet 
Nam) from first group represent Southeast 
Asia. Details of other seven groups are given 
in bars below. 
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Africa is potential reservoir and importer of 
Dengue cases [13,18]. But most of the cases 
till now have gone unreported due to lack of 
clinical and serological surveillance. 
Numbers of people returning home after 
visiting Africa are detected dengue positive. 
So, an indirect realization of the dengue 
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affected countries has been made. This has 
flagged South Africa as leading country 
followed by Senegal, Burkina Faso and 
Guinea[19]. Other countries in which 
dengue cases were reported include Mali, 
Gabon, Cote d I’voire and Saudi Arabia 
during 2006-2009. But as news reports are 
the only source of data, so we have not 
included these numbers in calculation of 
total number of patients around the planet. 
In Mexico, Nicaragua, Venezuela, 
Colombia and Honduras most of the fatal 
cases occur among children <15 years of age 
[20,21].  
Case distribution at Hot Spot dengue 
regions of the world: 
There are 5 hot spot regions of the world 
according to dengue prevalence during 
2000-2009. We found 82 countries in these 
regions where dengue have its significant 
epidemic. These regions include Americas, 
Southeast Asia, Southern and Eastern 
Caribbean’s countries and south Pacific 
countries. Distribution of cases is as under in 
percentage in figure 1: 
 
 
 
 
Cases from Pakistan: 
Neither WHO nor any other source has 
shown exact data of 2011 epidemic in 
Pakistan. Approximately134,061 patients 
presented themselves for dengue diagnosis 
only at one hospital in Lahore city of 
Pakistan. 7415 patients, among total 
presented cases, found ELISA positive for 
dengue. A model research was conducted on 
1004 patients presenting signs and 
symptoms of typical dengue illness. All 
patients were screened through standard 
ELISA kit diagnostic automation (ISO 
certified) 1-4 for the confirmation of dengue 
virus [for all the 4 serotypes]. Examined sera 
were paired i.e. sera taken at the time of 
admission and sera taken after 10 days 
interval. Titer of IgG and IgM was set as 
conclusive for declaring patients positive or 
negative. Titer greater than 0.8 ± 0.2 for IgG 
or IgM was optimized as standard for 
positive patients. Positive and negative 
controls were maintained for test quality 
control. Among those 1004 suspected 
individuals, 741 (73.80%) were found 
positive for dengue virus while 263 
(26.20%) were negative. 241 (33%) were 
representing female gender while 500 (67%) 
were male patients. IgG and IgM ELISA 
pattern was different from each other. 
Patients showing reaction to IgG were 483 
while to IgM there were 463. 205 (27.67%) 
patients had shown reaction against both 
IgG and IgM antibodies. Age pattern of the 
patients was a bit out of the reported trend. 
Children of age 5 year or less were the least 
affected population i.e. 5/741 (0.67%). Most 
affected individual found were of the age 
15-25 years i.e. 225/741 (30.36%). Rest of 
the patients were grouped on the age basis as 
Figure 1: A) Case distribution around the globe 
during 2000-2009. B) Showing the global dengue 
infection trend during 2000-2009. 
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: >5≤15=65 (8.77%), >25≤35=170 
(22.94%), >35≤45=121 (16.33%), 
>45≤55=73 (9.85%), >55≤65=46 (6.20%) 
and >65=31 (4.18%).  Same trend in the age 
groups were observed in all 1004 dengue 
suspected cases (fig 2). 19 patients could not 
survive the infection (mortality rate 2.56%). 
All of these patients belonged to Lahore 
city. Pakistan’s other cities where endemic 
showed up like Karachi and Faisalabad had 
almost same situation and trends but at less 
magnitude. 
Although National Disaster Management 
Authority (NDMA), Pakistan has issued a 
country map showing number of patient 
district wise for 2011 epidemic Fig 3. But 
this map is not a true picture as this just 
represents cases of two provinces Punjab 
and Sindh. 
 
 
 
 
 
 
 
Google Dengue Trends: 
We consulted Google Dengue Trends 
(GDT) to give glimpse of dengue in three 
countries (Brazil, Indonesia and India) 
having a major dengue burden around the 
world. 
 
 
 
 
 
 
 
 
 
Case Fatality Ration (CFR): 
Figure 2: Results of the model research 
conducted on 1004 patients at a public hospital in 
Lahore, Pakistan during October 2011-December 
2011. A) Confirmed vs clinical cases, B) Male: 
Female among confirmed patients, C) Age 
groups of diseased persons, D) Age groups of 
clinical cases, E) Death rate in confirmed cases 
(CFR). 
Figure 3:Number of dengue cases (District wise) shown by 
NDMA, Pakistan in map of Pakistan. 
Figure 4: Dengue activity in Brazil, India and Indonesia 
(image taken from Google Dengue Trends). 
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We have calculated Case Fatality Ratio on 
different parameters than WHO. As WHO 
figures do not depict the original picture but 
exaggerate the facts. For example for 2002 
in Bolivia the FCR is given as 100 which 
could not be set as reference because all 
effected patients could not die 
(http://apps.who.int/globalatlas/dataQuery/re
portData.asp?rptType=1). We established 
dengue CFR on the basis of total clinical 
cases presented rather than just calculating 
on the ground of DHF cases or laboratory 
confirmed cases. 
 
 
 
According to data provided by authentic 
sources we estimate that a total of 24,956 
lives lost during 2000-2009. This is by no 
means the actual deaths figure. There are 
number of reasons behind the low 
anticipated toll. After diagnosis, a major 
fraction of dengue patients do not or could 
not stay at hospital. So if it turns fatal then 
there is no record on hospital or any other 
official database. For example just in 
Pakistan, a page in Wikipedia claims that 
more than 50 people died of dengue during 
2006 epidemic though don’t have any 
reference and neither Pakistan’s statistics 
have been mentioned at any other 
international database. But there was 
epidemic at a very large level and it must 
have had claimed lives in Pakistan for the 
given period so we can say that deaths are 
considerably high than reported numbers. 
Death rate/disease in Asian countries is very 
much less as compared to total number of 
appeared cases. This supports the idea that 
Asian and Black people are much more 
resistant to dengue than White people. A 
ratio of Asian & Caucasian vs. African in 
1997 was estimated 5:1  for Cuban epidemic 
[22,23]. For reported cases, death map of 
dengue patients is given below. 
 
 
The Next Decade: 
Mosquitoes’ population in Europe is 
increasing at significant pace. So, in ongoing 
decade, Europe is forecasted to be the next 
play ground for dengue. Italy, France, 
Monaco and other countries near the 
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Figure 5: World Dengue Death Map for the 1st decade of 21st 
century (2000-2009). 
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Mediterranean Sea are at greater risk due to 
presence of A. Aegypti and A. Albocatus. 
Economic burden is also likely to be 
increased. In past decade, US$238 (on 
average) was the cost being spent per 
dengue patient in 7 major dengue struck 
countries [24]. However expenses can be 
controlled if more budgets are allocated in 
the head of controlling measures. Vector 
controlling measures has successfully 
knocked down dengue with a significant 
decrease in affected population in country 
like Pakistan for the year 2012. 
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